Two different fibrinogen gene mutations associated with bleeding in the same family (AαGly13Glu and γGly16Ser) and their impact on fibrin clot properties: Fibrinogen Krakow II and Krakow III

Thrombosis and Haemostasis

Volumn 106, Issue 3, 2011, Pages 558-560

  Pietrys, Danuta ^a   Balwierz, Walentyna ^a   Iwaniec, Teresa ^b   Vorjohann, Silja ^c   Neerman Arbez, Marguerite ^c,d   Undas, Anetta ^b  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

AGED; BLEEDING; CASE REPORT; CHILD; DYSFIBRINOGENEMIA; EPISTAXIS; FGA GENE; FGB GENE; FGG GENE; FIBRIN CLOT; GENE; GENE MUTATION; HETEROZYGOSITY; HUMAN; LETTER; LYME DISEASE; MALE; MISSENSE MUTATION; MUCOCUTANEOUS BLEEDING; PARTIAL THROMBOPLASTIN TIME; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHOOL CHILD; THROMBIN TIME; THROMBOCYTE COUNT; TOOTH EXTRACTION;

ADULT; BLOOD COAGULATION DISORDERS; CHILD; DNA MUTATIONAL ANALYSIS; FIBRINOGEN; GENETIC ASSOCIATION STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLAND; PROTHROMBIN TIME; RECURRENCE;

EID: 80052315302     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-02-0102     Document Type: Letter

References (9)

1. Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol 2001; 114: 249-257.
2. Neerman-Arbez M, de Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of ten novel mutations. Hum Mut 2007; 28: 540-553.
3. Neerman-Arbez M, de Moerloose P, Honsberger A, et al. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum Genet 2001; 108: 237-240.
4. Kotlin R, Zichova K, Suttnar J, et al. Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy. Thromb Res 2011; 127: 277-278.
5. Undas A, Zawilska K, Ciesla-Dul M, et al. Altered fibrin clot structure/function in patients with idiopathic venous thrombembolism and in their relatives. Blood 2009; 114: 4272-4278.
6. Undas A, Pastuszczak M, Iwaniec T, et al. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze). Thromb Haemost 2010; 104: 415-417.
7. Undas A, Zdziarska J, Basa J, et al. Fibrinogen Krakow: a novel hypodysfibrinogenemia mutation in FGG (Asn325Ile) affecting fibrin structure and function. Thromb Haemost 2009; 101: 975-976.
8. Neerman Arbez M, de Moerloose P. Hereditary fibrinogen abnormalities. In: Williams' Hematology 8th Ed, Mc-Graw-Hill New York 2010, pp. 2051-2068.
9. Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.